Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Autor: Lorenc ZP, Adelglass JM, Avelar RL, Baumann L, Beer KR, Cohen JL, Cox SE, Dayan SH, Dover JS, Downie JB, Draelos ZD, Goldman MP, Gross JE, Joseph JH, Kaufman-Janette J, Moy RL, Nestor M, Schlessinger J, Smith SR, Weiss RA
Jazyk: angličtina
Zdroj: Aesthetic surgery journal [Aesthet Surg J] 2021 Nov 12; Vol. 41 (12), pp. 1494-1495.
DOI: 10.1093/asj/sjab230
Databáze: MEDLINE